SCHEMBL7672891

SCHEMBL7672891

CC(C)(C)[Si](C)(C)Oc1ccc(C=O)c(NC(=O)O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.40
CA1 P00915 4/20 0.40
CA9 Q16790 4/20 0.40
PREP P48147 4/20 0.39
ELANE P08246 1/20 0.36
PRTN3 P24158 1/20 0.36
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
ERN1 O75460 1/20 0.34
TRIM24 O15164 1/20 0.34
TYR P14679 1/20 0.34
TRIM33 Q9UPN9 1/20 0.34
ALDH1A1 P00352 1/20 0.32
ATM Q13315 1/20 0.32
RAF1 P04049 1/20 0.31
MAPT P10636 2/20 0.31
LMNA P02545 1/20 0.31
TSHR P16473 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6162530 0.86 CA12 (0.38) CA12CA1CA9PREPELANE
SCHEMBL22078670 0.79 CA12 (0.47) CA12CA1CA9PREPHSP90AA1
SCHEMBL7618394 0.77 TYR (0.58) CA12CA1CA9PREPHSP90AA1
SCHEMBL14240879 0.77 CA12 (0.48) CA12CA1CA9PREPHSP90AA1
SCHEMBL2199657 0.77 CA12 (0.48) CA12CA1CA9PREPHSP90AA1
SCHEMBL14697028 0.76 ERN1 (0.60) CA12CA1CA9ERN1TRIM24
SCHEMBL19810818 0.76 ALDH1A1 (0.49) CA12CA1CA9PREPHSP90AA1
SCHEMBL31587586 0.76 ERN1 (0.60) CA12CA1CA9ERN1TRIM24
SCHEMBL2511093 0.75 CA12 (0.46) CA12CA1CA9PREPHSP90AA1
SCHEMBL17494765 0.75 CA12 (0.46) CA12CA1CA9PREPHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6479512-B1 TO TREAT TYROSINE KINASE-DEPENDENT DISEASES AND CONDITIONS, SUCH AS ANGIOGENESIS, CANCER, TUMOR GROWTH, ATHEROSCLEROSIS, AGE RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY, INFLAMMATORY DISEASES, ETC. MERCK & CO., INC. 2002-11-12 US disclosed